MA26557A1 - Determination du caractere anormal de croissance cellulaire - Google Patents

Determination du caractere anormal de croissance cellulaire

Info

Publication number
MA26557A1
MA26557A1 MA25308A MA25308A MA26557A1 MA 26557 A1 MA26557 A1 MA 26557A1 MA 25308 A MA25308 A MA 25308A MA 25308 A MA25308 A MA 25308A MA 26557 A1 MA26557 A1 MA 26557A1
Authority
MA
Morocco
Prior art keywords
cell growth
proteins
determination
growth abnormalities
cancerous
Prior art date
Application number
MA25308A
Other languages
English (en)
French (fr)
Inventor
Haydn Williams Gareth
Coleman Nicholas
Alfred Laskey Ronald
Original Assignee
Cancer Res Compaign Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722217.8A external-priority patent/GB9722217D0/en
Priority claimed from GBGB9724134.3A external-priority patent/GB9724134D0/en
Priority claimed from GBGB9804156.9A external-priority patent/GB9804156D0/en
Priority claimed from GBGB9810560.4A external-priority patent/GB9810560D0/en
Priority claimed from GBGB9817075.6A external-priority patent/GB9817075D0/en
Application filed by Cancer Res Compaign Technology filed Critical Cancer Res Compaign Technology
Publication of MA26557A1 publication Critical patent/MA26557A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Liquid Crystal Substances (AREA)
  • Eye Examination Apparatus (AREA)
MA25308A 1997-10-21 1998-10-21 Determination du caractere anormal de croissance cellulaire MA26557A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9722217.8A GB9722217D0 (en) 1997-10-21 1997-10-21 Determination of cellular growth abnormality
GBGB9724134.3A GB9724134D0 (en) 1997-11-14 1997-11-14 Determination of cellular growth abnormality
GBGB9804156.9A GB9804156D0 (en) 1998-02-26 1998-02-26 Determination of cellular growth abnormality
GBGB9810560.4A GB9810560D0 (en) 1998-05-15 1998-05-15 Determination of cellular growth abnormality
GBGB9817075.6A GB9817075D0 (en) 1998-08-05 1998-08-05 Determination of cellular growth abnormality

Publications (1)

Publication Number Publication Date
MA26557A1 true MA26557A1 (fr) 2004-12-20

Family

ID=27517431

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25308A MA26557A1 (fr) 1997-10-21 1998-10-21 Determination du caractere anormal de croissance cellulaire

Country Status (23)

Country Link
EP (1) EP1025444B1 (xx)
JP (2) JP2000511291A (xx)
CN (1) CN1282422A (xx)
AT (1) ATE290213T1 (xx)
AU (1) AU751754B2 (xx)
BR (1) BR9813127A (xx)
CA (1) CA2305872C (xx)
CO (1) CO5080817A1 (xx)
DE (1) DE69829198T2 (xx)
DK (1) DK1025444T3 (xx)
ES (1) ES2239407T3 (xx)
GB (1) GB2332515B (xx)
HU (1) HUP0004134A2 (xx)
IL (1) IL135602A0 (xx)
IS (1) IS5456A (xx)
MA (1) MA26557A1 (xx)
NO (1) NO20002044L (xx)
NZ (1) NZ503996A (xx)
PE (1) PE20000121A1 (xx)
PL (1) PL340057A1 (xx)
PT (1) PT1025444E (xx)
SK (1) SK5592000A3 (xx)
WO (1) WO1999021014A1 (xx)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE10063112A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
CN1554025A (zh) 2001-03-12 2004-12-08 Īŵ���ɷ����޹�˾ 患病状态的细胞为基础的检测和鉴别
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
US7361511B2 (en) * 2002-08-20 2008-04-22 Millenium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
WO2004074301A2 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Differentially expressed nucleic acids that correlate with ksp expression
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
EP1688503A4 (en) * 2003-10-20 2007-10-31 Sysmex Corp METHOD FOR THE TREATMENT OF CELLS
KR100882249B1 (ko) * 2004-03-24 2009-02-06 트리패스 이미징, 인코포레이티드 자궁경부 질환의 검사 방법 및 조성물
US7595380B2 (en) * 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
GB0518877D0 (en) * 2005-09-15 2005-10-26 Medical Res Council Markers and methods
US7632498B2 (en) 2005-12-19 2009-12-15 Tripath Imaging, Inc. MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
EP2479285B1 (en) 2006-01-05 2014-05-14 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
EP1996731A2 (en) 2006-03-20 2008-12-03 The Ohio State University Research Foundation Microrna fingerprints during human megakaryocytopoiesis
DE102006020852A1 (de) 2006-05-04 2007-11-15 Robert Bosch Gmbh Gasdruckbehälter für gasbetriebene Kraftfahrzeuge
EP2653561B1 (en) 2007-08-03 2016-03-02 The Ohio State University Research Foundation Ultraconserved regions encoding ncRNAs
GB0811567D0 (en) 2008-06-24 2008-07-30 Cytosystems Ltd Assay
CN102803511A (zh) 2009-11-23 2012-11-28 俄亥俄州立大学 用于影响肿瘤细胞生长、迁移和侵袭的材料和方法
GB0921873D0 (en) * 2009-12-15 2010-01-27 Cytosystems Ltd Assay
JP5931897B2 (ja) 2010-11-12 2016-06-08 ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイションＴｈｅ Ｏｈｉｏ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ マイクロｒｎａ−２１、ミスマッチ修復および結腸直腸癌に関連する物質および方法
US10758619B2 (en) 2010-11-15 2020-09-01 The Ohio State University Controlled release mucoadhesive systems
WO2012090479A1 (en) * 2010-12-28 2012-07-05 Oncotherapy Science, Inc. Mcm7 as a target gene for cancer therapy and diagnosis
AU2012323924A1 (en) 2011-10-14 2014-05-29 The Ohio State University Methods and materials related to ovarian cancer
WO2013090556A1 (en) 2011-12-13 2013-06-20 The Ohio State University Methods and compositions related to mir-21 and mir-29a, exosome inhibition, and cancer metastasis
CA2860549A1 (en) * 2012-01-05 2013-07-11 Christophe Cazaux Signature for the diagnosis of lung cancer aggressiveness and genetic instability
WO2013110053A1 (en) 2012-01-20 2013-07-25 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
US11306364B2 (en) 2012-02-18 2022-04-19 Duke University TERT promoter mutations in gliomas and a subset of tumors
US10711310B2 (en) * 2013-02-18 2020-07-14 Duke University Tert promoter mutations in gliomas and a subset of tumors
GB201412731D0 (en) * 2014-07-17 2014-09-03 Immunocore Ltd & Adaptimmune Ltd Peptides
AU2016261279B2 (en) * 2015-05-10 2020-12-10 Ventana Medical Systems, Inc. Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
US11519916B2 (en) 2015-06-08 2022-12-06 Arquer Diagnostics Limited Methods for analysing a urine sample
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies
ES2911415T3 (es) 2015-06-08 2022-05-19 Arquer Diagnostics Ltd Métodos y kits
GB201511196D0 (en) 2015-06-25 2015-08-12 Cytosystems Ltd Monoclonal antibodies
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用
CN106636343B (zh) * 2016-11-04 2021-03-19 深圳大学 一种检测口腔癌的标志物及其试剂盒
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
CN112946253B (zh) * 2019-12-11 2022-11-08 广东菲鹏生物有限公司 用于免疫诊断试剂中固相载体的封闭阶段处理剂及应用和产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144485A (da) * 1984-03-30 1985-10-01 Syntex Inc Monoklonale antistoffer
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
EP0812594A1 (en) * 1996-06-13 1997-12-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
WO1999021014A1 (en) 1999-04-29
DE69829198D1 (de) 2005-04-07
DK1025444T3 (da) 2005-06-27
IS5456A (is) 2000-04-17
BR9813127A (pt) 2000-08-15
DE69829198T2 (de) 2006-01-12
CN1282422A (zh) 2001-01-31
HUP0004134A2 (en) 2001-03-28
PL340057A1 (en) 2001-01-15
PT1025444E (pt) 2005-07-29
AU9550298A (en) 1999-05-10
ES2239407T3 (es) 2005-09-16
ATE290213T1 (de) 2005-03-15
IL135602A0 (en) 2001-05-20
CO5080817A1 (es) 2001-09-25
AU751754B2 (en) 2002-08-29
GB2332515A (en) 1999-06-23
GB2332515B (en) 1999-12-15
SK5592000A3 (en) 2000-10-09
JP2003240786A (ja) 2003-08-27
GB9823069D0 (en) 1998-12-16
NZ503996A (en) 2002-04-26
EP1025444B1 (en) 2005-03-02
JP2000511291A (ja) 2000-08-29
NO20002044L (no) 2000-06-07
PE20000121A1 (es) 2000-02-17
EP1025444A1 (en) 2000-08-09
JP3774196B2 (ja) 2006-05-10
CA2305872A1 (en) 1999-04-29
CA2305872C (en) 2008-02-19
NO20002044D0 (no) 2000-04-18

Similar Documents

Publication Publication Date Title
MA26557A1 (fr) Determination du caractere anormal de croissance cellulaire
Garewal et al. Reduced bile acid-induced apoptosis in “normal” colorectal mucosa: a potential biological marker for cancer risk
AU2006200645B2 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
AU2002246970B2 (en) Detection of survivin in the biological fluids of cancer patients
Bostwick Natural history of early bladder cancer
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
CA2487048A1 (en) Method for solution based diagnosis
DK0507852T3 (da) Gen deleteret hos mennesker med kolorektal cancer
AU2003214909A1 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
Testori et al. Primary melanoma: from history to actual debates
AP2000001917A0 (en) Gene encoding labyrinthin, a marker for cancer.
DK0566571T3 (da) Diagnose af metastatisk cancer ved hjælp af mts-1-genet
Reis-Filho et al. p63 expression in sarcomatoid/metaplastic carcinomas of the breast.
AR014382A1 (es) Determinacion de anormalidad en el crecimiento celular
TH41035B (th) การกำหนดของความผิดปกติในการเจริญเติบโตของเซลล์
TH41035A (th) การกำหนดของความผิดปกติในการเจริญเติบโตของเซลล์
Gupta et al. Tissue isoantigens A, B, and H in carcinoma of the cervix uteri: their clinical significance
Yildirim et al. Significance of p53 and bcl-2 immunoexpression in the prognosis of laryngeal squamous cell carcinoma
Ye et al. Study on the different expression of molecular markers between cardiac cancer and distal gastric cancer and their correlations with clinicopathological features
Mavligit et al. Reversible elevation of plasma CEA associated with iatrogenic unilateral hydronephrosis in a patient operated for colorectal cancer
Pujol et al. Long term survival after pulmonary resection for small cell carcinoma of the lung.
Veale et al. Pulmonary haemorrhage in Henoch-Schonlein purpura.
EP1243653A3 (en) E25a protein, methods for producing and use thereof
Wild et al. canccr (NscLc) andupeciallythc ssuewrusctllsubtype,(2) toasscss
AU2007202539A1 (en) Detection of survivin in the biological fluids of cancer patients